Page results
-
We are making it easier and safer for patients to be seen in an Emergency Department (ED) or Accident and Emergency (A&E) department without waiting for long periods of time.
-
Dr Nagendran is a consultant neurophysiologist eripheral nerve and muscle disease, skeletal muscle channelopathies, nerve excitability disorders
-
This information is intended for patients who are receiving GnRH-a injections as part of their treatment at UCLH.
-
Information about the council of governors at University College London Hospitals NHS Foundation Trust
-
Dr Sen is a triple accredited consultant physician in stroke, geriatric and general internal medicine
-
A guide to choosing diabetes technology for UCLH patients
-
Become a member of UCLH. We want to better reflect the diversity of the communities we serve and meet the needs of our local community, patients and staff.
-
This page has been written for patients who are having radiotherapy or proton beam therapy to the oesophagus.
-
There is industrial action by resident doctors (formerly known as junior doctors) from 7am on Friday 25 July until 7am on Wednesday 30 July.
-
The Haemophagocytic Lymphohistiocytosis (HLH) Service was established at UCLH to offer high-quality care for people suspected of having HLH.
File results
-
FOI/2024/0697 - Autism spectrum disorder (ASD)/ attention deficit hyperactivity disorder (ADHD) and mental health services
-
FOI/2024/0696 - Various IT systems used at Trust
-
FOI/2024/0695 - Air filtration used/ air exchange rate across Trust
-
FOI/2024/0693 - Patients overhead or ceiling track hoists portable/ mobile hoists installed
-
FOI/2024/0692 - Integrated Care Board (ICB) expenditure sign-off process 2023/24
-
FOI/2024/0691 - Information distributed to pregnant/ post-partum women for infant feeding
-
FOI/2024/0690 - Mechanical transport ventilation/ ventway sparrow transport ventilator
-
FOI/2024/0666 - Non-emergency patient transport services (NEPTS) and pathology specimen courier services
-
FOI/2024/0664 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma